The Food and Drug Administration has confirmed shortages of Adderall and generic versions of the drug, saying patients can use alternative treatments until supply issues are resolved. The US Food and Drug Administration said this week what patients, manufacturers and retailers have been signaling for months: that patients with ADHD have difficulty obtaining medications that can help them focus. The drug may also be used to treat a sleep disorder, according to the Food and Drug Administration. “We continue to use all tools at our disposal to help provide supplies to patients,” the Food and Drug Administration said on Wednesday. A Sandoz spokeswoman said Friday that the company had no shortage of generic Adderall and that the FDA frequently requested supply updates.

Source: Wall Street Journal October 15, 2022 04:48 UTC